Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Suneet Mittal

Clinical Cardiac Electrophysiology Paramus, NJ Medical Doctor

NPI 1477666923 CMS profile 66498

140 E Ridgewood Ave Ste 720, Ste 720, Paramus, NJ 07652

Open in the dashboard

General payments

$721,843

965 records reported · program years 2019–2025

Research payments

$15,706

Paid to them · 23 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,624,914 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Suneet Mittal of Paramus, NJ is reported in the CMS Open Payments database as having received $721,843 across 965 general payments and $15,706 in research payments paid to them. Separately, studies naming them as principal investigator received $1,624,914 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

12 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $153,099 158
2024 General $161,534 177
2024 Research $375 1
2023 General $101,086 173
2023 Research $800 3
2022 General $83,852 157
2022 Research $2,250 7
2021 General $75,405 90
2021 Research $8,156 9
2020 General $51,572 44
2020 Research $4,125 3
2019 General $95,294 166

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Suneet Mittal
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Suneet Mittal were reported at $153,099. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Suneet Mittal Clinical Cardiac Electrophysiology median Middle half National median
2019 $95,294 $2,361 $585–$8,260 $163
2020 $51,572 $993 $247–$4,351 $114
2021 $75,405 $1,185 $326–$4,739 $132
2022 $83,852 $2,073 $554–$6,789 $149
2023 $101,086 $2,568 $759–$8,159 $160
2024 $161,534 $2,557 $703–$7,403 $164
2025 $153,099 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $253,495 301 payments
  2. Medtronic, Inc. $206,828 251 payments
  3. Medtronic Vascular, Inc. $94,867 95 payments
  4. Impulse Dynamics (USA) Inc. $24,914 34 payments
  5. Biosense Webster, Inc. $24,358 35 payments
  6. iRhythm Technologies, Inc. $24,213 20 payments
  7. Philips Electronics North America Corporation $19,763 11 payments
  8. Cardiva Medical, Inc. $12,816 22 payments
  9. CVRx, Inc. $9,012 16 payments
  10. Sanofi-Aventis U.S. LLC $8,797 3 payments
  11. Other $42,782 177 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $299,741 92 payments
  2. Consulting Fee $287,541 165 payments
  3. Travel and Lodging $65,171 226 payments
  4. Food and Beverage $34,625 460 payments
  5. Honoraria $20,600 11 payments
  6. Grant $6,500 1 payment
  7. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $2,500 1 payment
  8. Acquisitions $2,273 1 payment
  9. Compensation for serving as faculty or as a speaker for a medical education program $2,100 1 payment
  10. Current or prospective ownership or investment interest $504 2 payments
  11. Other $289 5 payments
Products named General payments · program years 2019–2025
  1. ZIO XT Patch $24,200 19 payments
  2. CLINICAL TRIAL PRODUCT Clinical Trial Product_CRM $24,043 18 payments
  3. Carto 3 $17,555 11 payments
  4. OPTIMIZER Cardiovascular Device $15,987 25 payments
  5. OPTIMIZER Cardiovascular Device $15,987 25 payments
  6. General - Therapies General - Therapies_EP $15,594 6 payments
  7. General - Therapies General - Therapies_CRM $15,357 28 payments
  8. WATCHMAN Access System $13,375 17 payments
  9. Arctic Front $12,596 12 payments
  10. CLINICAL TRIAL PRODUCT Clinical Trial Product $10,295 14 payments
  11. Other $167,290 445 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic, Inc. $10,969 18 payments
  2. Medtronic Vascular, Inc. $4,125 3 payments
  3. CVRx, Inc. $438 1 payment
  4. Boston Scientific Corporation $175 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 11 drugs

Part D claims

421

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$246,236

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

48%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 115 $141,643
Xarelto Rivaroxaban Brand 43 $67,030
Multaq Dronedarone Hcl Brand 12 $22,510
Dofetilide Generic 38 $8,813
Ranolazine Er Ranolazine Brand 32 $3,810
Metoprolol Succinate Generic 62 $1,071
Amiodarone Hcl Generic 33 $827
Spironolactone Generic 27 $194
Atorvastatin Calcium Generic 17 $169
Losartan Potassium Generic 29 $133

The 10 drugs with the highest cost, of 11 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 69 billing codes

Paid by Medicare

$287,268

Medicare's payments for the services billed

Medicare patients

515

Average age 78

Services billed

4,218

191 women, 324 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 75%
Ischemic heart disease 58%
Arthritis 54%
Heart failure 40%
Diabetes 37%
Chronic kidney disease 29%
Cancer 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
CAMZYOS
$15 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

988 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record